Sjogren’s Syndrome
Clinical Research Institute of Michigan – Shores Rheumatology Primary Coordinator: Amelia Paliewicz 586-598-3329 X 201 Indication: Sjogren’s Syndrome Enrollment Status: Closed Protocol: HZNP-DAZ-301, HZNP-DAZ-301 HZNP-DAZ-304 “Oasis” Drug: Dazodalibep Sponsor: Horizon/Amgen […]
Rheumatoid Arthritis
Clinical Research Institute of Michigan – Shores Rheumatology Primary Coordinator: Amelia Paliewicz 586-598-3329 X 201 Indication: Rheumatoid Arthritis Enrollment Status: Closed Protocol: GS-US-417-0304 Drug: Filgotinib Sponsor: Gilead Description: A Multicenter, […]
Psoriatic Arthritis
Clinical Research Institute of Michigan – Shores Rheumatology Primary Coordinator: Amelia Paliewicz 586-598-3329 X 201 Indication: Psoriatic Arthritis Enrollment Status: Closed Protocol: I1F-MC-RHDE Drug: tirzepatide/ ixekizumab Sponsor: Eli Lilly Description: […]